Shopping Cart 0
Cart Subtotal
AED 0

RedHill Biopharma Ltd (RDHL) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 459

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 918

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 1376

Details

RedHill Biopharma Ltd (RDHL)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

RedHill Biopharma Ltd (RedHill) is a biopharmaceutical company that develops and commercializes therapeutics in the areas of gastroenterology (GI) and cancer. The company's commercial product portfolio consists of Donnatal for IBS and acute enterocolitis; Mytesi; Esomeprazole Strontium Delayed-Release Capsules 49.3 mg for GERD and other GI conditions; and EnteraGam, a medical food intended for the dietary management. It sells these specialty GI products in select US territories. RedHill is investigating pipeline candidates for the treatment of GI disorders and cancer that include helicobacter pylori infection, Crohn's disease, multiple sclerosis and pancreatic cancer among others. RedHill is headquartered in Tel Aviv, Israel.

RedHill Biopharma Ltd Key Recent Developments

May 28,2019: RedHill Biopharma appoints Dr. June Almenoff as Chief Scientific Officer

May 07,2019: RedHill Biopharma reports first quarter 2019 financial results and operational highlights

Feb 26,2019: RedHill Biopharma provides full-Year 2018 financial results and operational highlights

Nov 13,2018: RedHill Biopharma reports third quarter 2018 financial results and business highlights

Aug 30,2018: RedHill Biopharma reports second quarter 2018 financial results and provides update on operations

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

RedHill Biopharma Ltd-Key Facts

RedHill Biopharma Ltd-Key Employees

RedHill Biopharma Ltd-Key Employee Biographies

RedHill Biopharma Ltd-Key Operational Employees

RedHill Biopharma Ltd-Major Products and Services

RedHill Biopharma Ltd-History

RedHill Biopharma Ltd-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

RedHill Biopharma Ltd-Business Description

RedHill Biopharma Ltd-Corporate Strategy

RedHill Biopharma Ltd-SWOT Analysis

SWOT Analysis-Overview

RedHill Biopharma Ltd-Strengths

RedHill Biopharma Ltd-Weaknesses

RedHill Biopharma Ltd-Opportunities

RedHill Biopharma Ltd-Threats

RedHill Biopharma Ltd-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

RedHill Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

RedHill Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

RedHill Biopharma Ltd, Recent Deals Summary

Section 5-Company's Recent Developments

May 28, 2019: RedHill Biopharma appoints Dr. June Almenoff as Chief Scientific Officer

May 07, 2019: RedHill Biopharma reports first quarter 2019 financial results and operational highlights

Feb 26, 2019: RedHill Biopharma provides full-Year 2018 financial results and operational highlights

Nov 13, 2018: RedHill Biopharma reports third quarter 2018 financial results and business highlights

Aug 30, 2018: RedHill Biopharma reports second quarter 2018 financial results and provides update on operations

Aug 09, 2018: RedHill Biopharma Announces Pricing of USD 25 Million Underwritten Offering

Jul 23, 2018: RedHill Biopharma announces uplisting to nasdaq global market

May 08, 2018: RedHill Biopharma Reports First Quarter 2018 Financial Results

Apr 09, 2018: RedHill Biopharma Provides Semi-Annual Business Update

Feb 22, 2018: RedHill Biopharma Provides Fourth Quarter and Full-Year 2017 Investor Update

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

RedHill Biopharma Ltd, Performance Chart (2014-2018)

RedHill Biopharma Ltd, Ratio Charts

RedHill Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

RedHill Biopharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

RedHill Biopharma Ltd, Key Facts

RedHill Biopharma Ltd, Key Employees

RedHill Biopharma Ltd, Key Employee Biographies

RedHill Biopharma Ltd, Key Operational Employees

RedHill Biopharma Ltd, Major Products and Services

RedHill Biopharma Ltd, History

RedHill Biopharma Ltd, Subsidiaries

RedHill Biopharma Ltd, Key Competitors

RedHill Biopharma Ltd, Ratios based on current share price

RedHill Biopharma Ltd, Annual Ratios

RedHill Biopharma Ltd, Annual Ratios (Cont...1)

RedHill Biopharma Ltd, Interim Ratios

RedHill Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

RedHill Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

RedHill Biopharma Ltd, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

RedHill Biopharma Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Adare Pharmaceuticals Inc

Unipharm Ltd

Therapix Biosciences Ltd

Dexcel PT Israel Ltd

Nutrinia Ltd

Company Profile

Company Profile Title

RedHill Biopharma Ltd (RDHL)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

RedHill Biopharma Ltd (RedHill) is a biopharmaceutical company that develops and commercializes therapeutics in the areas of gastroenterology (GI) and cancer. The company's commercial product portfolio consists of Donnatal for IBS and acute enterocolitis; Mytesi; Esomeprazole Strontium Delayed-Release Capsules 49.3 mg for GERD and other GI conditions; and EnteraGam, a medical food intended for the dietary management. It sells these specialty GI products in select US territories. RedHill is investigating pipeline candidates for the treatment of GI disorders and cancer that include helicobacter pylori infection, Crohn's disease, multiple sclerosis and pancreatic cancer among others. RedHill is headquartered in Tel Aviv, Israel.

RedHill Biopharma Ltd Key Recent Developments

May 28,2019: RedHill Biopharma appoints Dr. June Almenoff as Chief Scientific Officer

May 07,2019: RedHill Biopharma reports first quarter 2019 financial results and operational highlights

Feb 26,2019: RedHill Biopharma provides full-Year 2018 financial results and operational highlights

Nov 13,2018: RedHill Biopharma reports third quarter 2018 financial results and business highlights

Aug 30,2018: RedHill Biopharma reports second quarter 2018 financial results and provides update on operations

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

RedHill Biopharma Ltd-Key Facts

RedHill Biopharma Ltd-Key Employees

RedHill Biopharma Ltd-Key Employee Biographies

RedHill Biopharma Ltd-Key Operational Employees

RedHill Biopharma Ltd-Major Products and Services

RedHill Biopharma Ltd-History

RedHill Biopharma Ltd-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

RedHill Biopharma Ltd-Business Description

RedHill Biopharma Ltd-Corporate Strategy

RedHill Biopharma Ltd-SWOT Analysis

SWOT Analysis-Overview

RedHill Biopharma Ltd-Strengths

RedHill Biopharma Ltd-Weaknesses

RedHill Biopharma Ltd-Opportunities

RedHill Biopharma Ltd-Threats

RedHill Biopharma Ltd-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

RedHill Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

RedHill Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

RedHill Biopharma Ltd, Recent Deals Summary

Section 5-Company's Recent Developments

May 28, 2019: RedHill Biopharma appoints Dr. June Almenoff as Chief Scientific Officer

May 07, 2019: RedHill Biopharma reports first quarter 2019 financial results and operational highlights

Feb 26, 2019: RedHill Biopharma provides full-Year 2018 financial results and operational highlights

Nov 13, 2018: RedHill Biopharma reports third quarter 2018 financial results and business highlights

Aug 30, 2018: RedHill Biopharma reports second quarter 2018 financial results and provides update on operations

Aug 09, 2018: RedHill Biopharma Announces Pricing of USD 25 Million Underwritten Offering

Jul 23, 2018: RedHill Biopharma announces uplisting to nasdaq global market

May 08, 2018: RedHill Biopharma Reports First Quarter 2018 Financial Results

Apr 09, 2018: RedHill Biopharma Provides Semi-Annual Business Update

Feb 22, 2018: RedHill Biopharma Provides Fourth Quarter and Full-Year 2017 Investor Update

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

RedHill Biopharma Ltd, Performance Chart (2014-2018)

RedHill Biopharma Ltd, Ratio Charts

RedHill Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

RedHill Biopharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

RedHill Biopharma Ltd, Key Facts

RedHill Biopharma Ltd, Key Employees

RedHill Biopharma Ltd, Key Employee Biographies

RedHill Biopharma Ltd, Key Operational Employees

RedHill Biopharma Ltd, Major Products and Services

RedHill Biopharma Ltd, History

RedHill Biopharma Ltd, Subsidiaries

RedHill Biopharma Ltd, Key Competitors

RedHill Biopharma Ltd, Ratios based on current share price

RedHill Biopharma Ltd, Annual Ratios

RedHill Biopharma Ltd, Annual Ratios (Cont...1)

RedHill Biopharma Ltd, Interim Ratios

RedHill Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

RedHill Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

RedHill Biopharma Ltd, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

RedHill Biopharma Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Adare Pharmaceuticals Inc

Unipharm Ltd

Therapix Biosciences Ltd

Dexcel PT Israel Ltd

Nutrinia Ltd